2013年　業績一覧

  1. Asakawa Y, Takekawa H, Suzuki K, Toyoda S, Inoue T, Hirata K. Cardioembolic stroke due to isolated left ventricular non-compaction. Neurol Sci 2012; 33: 1493-1494

  2. Taguchi I, Abe S, Inoue T. Cyclophilin A is a promising predictor of coronary artery disease. Circ J 2013; 77: 321-322

  3. Adachi H, Hayashi T, Inoue T, Ishihara M, Ishii H, Iso H, Ito M, Kanamasa K, Kimura K, Miyazaki S, Mizuno K, Nagao K, Nakamura Y, Nohara R, Okumura K, Saito Y, Sakamoto T, Saku K, Sasaki J, Tanaka K, Tsutsui H (JCS Joint Working Group). Guidelines for secondary prevention of myocardial infarction (JCS 2011). Circ J 2013; 77: 231-248

  4. Sakamoto Y, Oyama J, Ikeda H, Kuroki S, Gondoh S, Iwamoto T, Uchida Y, Kodama K, Hiwatashi A, Shimomura M, Taguchi I, Inoue T, Node K. Effects of sitagliptin beyond glycemic control: focus on quality of life. Cardiovasc Diabetol 2013; 21: 12-35

  5. Otani N, Matsuda R, Oda K, Nishino S, Inoue T, Kaneko N. Protective effect of K201 on isoproterenol-induced and ischemic-reperfusion-induced ventricular arrhythmias in the rat: comparison with diltiazem. J Cardiovasc Pharmacol Ther 2013; 18: 184-90

  6. Taguchi I, Toyoda S, Arikawa T, Ogino Y, Koizumi S, Kikuchi M, Abe S, Node K, Inoue T. Is direct renin inhibition superior to angiotensin receptor blockade in the effects beyond blood pressure lowering? Jpn J Clin Physiol 2013; 43: 89-95

  7. Taguchi I, Oda K, Yoneda S, Kageyama M, Kanaya T, Toyoda S, Abe S, Node K, Inoue T. Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology intravascular ultrasound studies. Am J Cardiol 2013; 111: 1246-1252

  8. Taguchi I, Toyoda S, Takano K, Arikawa T, Kikuchi M, Ogawa M, Abe S, Node K, Inoue T. Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension. Hypertens Res 2013; 36: 608-613

  9. Amano H, Toyoda S, Arikawa T, Inami S, Otani N, Nishi Y, Kitagawa Y, Taguchi I, Abe S, Inoue T. Left ventricular function in pulmonary hypertension. Heart Vessels 2013; 28: 505-509

  10. Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation. Coron Artery Dis 2013; 24: 368-373

  11. Fukumoto Y, Yamada N, Matsubara H, Mizoguchi M, Uchino K, Yao A, Kihara Y, Kawano M, Watanabe H, Takeda Y, Adachi T, Osanai S, Tanabe N, Inoue T, Kubo A, Ota Y, Fukuda K, Nakano T, Shimokawa H. Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension. Circ J 2013; 77: 2619-2625

  12. Koshiji N, Taguchi I, Kageyama M, Nasuno T, Inami S, Arikawa T, Toyoda S, Kikuchi M, Abe S, Node K, Inoue T. Hypouricemic effects of angiotensin receptor blockers in high risk hypertension patients. Jpn J Clin Physiol 2013; 43: 151-157

  13. Koizumi S, Taguchi I, Kageyama M, Nasuno T, Inami S, Arikawa T, Toyoda S, Kikuchi M, Abe S, Inoue T. Effects of the oral adsorbent AST-120 on oxidative stress and uremic toxins in high risk chronic kidney disease patients. Jpn J Clin Physiol 2013; 43: 159-166

一覧へ戻る